# Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH

> **NCT06237348** · NA · COMPLETED · sponsor: **Physio-Assist** · enrollment: 50 (actual)

## Conditions studied

- Non-cystic Fibrosis Bronchiectasis
- Chronic Mucus Hypersecretion

## Interventions

- **DEVICE:** Simeox
- **COMBINATION_PRODUCT:** Control

## Key facts

- **NCT ID:** NCT06237348
- **Lead sponsor:** Physio-Assist
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-15
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06237348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06237348, "Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06237348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*